Headlands Technologies »

Cidara Therapeutics shares owned by Headlands Technologies

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.3M 29k 220.89

More positions owned by Headlands Technologies

Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Ishares Tr Iboxx Inv Cp Etf (LQD)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Booking Holdings (BKNG)
Electronic Arts (EA)
Bank of America Corporation (BAC)
Metropcs Communications (TMUS)
Exxon Mobil Corporation (XOM)
Roper Industries (ROP)
Nasdaq Omx (NDAQ)
Ross Stores (ROST)

View all positions for Headlands Technologies

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
HBK Investments
Fil
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
Leucadia National Corporation
Paradigm Biocapital Advisors
Balyasny Asset Management
Glazer Capital
Ikarian Capital

View all funds holding Cidara Therapeutics